பெருநாடி அடைப்பான் அமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பெருநாடி அடைப்பான் அமைப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பெருநாடி அடைப்பான் அமைப்பு Today - Breaking & Trending Today

Acurate neo2 TAVR Valve Demonstrate Reduced Paravalvular Leak and Low Permanent Pacemaker Rates


Acurate neo2 TAVR Valve Demonstrate Reduced Paravalvular Leak and Low Permanent Pacemaker Rates 
Late-breaking registry data at EuroPCR shows better outcomes than first-generation Acurate neo device.
The Acurate neo2 TAVR valve design enhancements include a 60% larger outer sealing skirt to conform to challenging anatomies. This has minimized paravalvular leaks and imporved clinical outcomes compared to the previous-generation Acurate neo Aortic Valve System.
May 26, 2021 Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress for the updated Boston Scientific Acurate neo2 transcatheter aortic valve replacement (TAVR) system demonstrated positive procedural performance. This including low rates of paravalvular leakage (PVL) and permanent pacemaker implementation (PPI), areas where the first generation Acurate neo heart valve did not perform as well.  ....

United States , Fondazione Poliambulanza Istituto Ospedaliero , Edwards Sapien , Andrea Buono , Ian Meredith , Chandan Devireddy , Juanf Granada , Society Of Cardiovascular Angiography , Emory University Hospital , Karolinska University Hospital Stockholm , Boston Scientific , Boston Scientific Acurate , Aortic Valve System , Results Show Promise , Registry Using , Valve System , Did Not Perform Well When Compared , Acurate Neo , Emory University Hospital Midtown , Cardiovascular Angiography , Accurate Neo , Key Takeaways , ஒன்றுபட்டது மாநிலங்களில் , எட்வர்ட்ஸ் சாபிிஎன் , ஈயந் மெரிடித் , சந்தன் டேவிரெட்டி ,

Late-Breaking Registry Data at EuroPCR Congress Demonstrate Reduced Paravalvular Leak and Low Permanent Pacemaker Rates for the ACURATE neo2™ Aortic Valve System


These real-world findings reinforce the effectiveness of the ACURATE 
neo2 valve design enhancements –including the 60% larger outer sealing skirt to conform to challenging anatomies – that have minimized PVL and shown excellent clinical outcomes in a broad spectrum of patients when compared to data collected with the previous-generation ACURATE
neo™ Aortic Valve System, said Dr. Ian Meredith, global chief medical officer, Boston Scientific.
EARLY neo2 Registry Results
The Early neo2 Registry, presented by Dr. Andreas Rück, interventional cardiologist, Karolinska University Hospital Stockholm, is the first large real-world report of clinical experience with the ACURATE 
neo2 device. Key findings from this retrospective analysis of 554 patients from 12 European centers included: ....

United States , Fondazione Poliambulanza Istituto Ospedaliero , Andrea Buono , Angela Mineo , Susie Lisa , Exchange Commission , Boston Scientific Corporation , Securities Exchange , Karolinska University Hospital Stockholm , Boston Scientific , Aortic Valve System , Securities Act , Securities Exchange Act , Risk Factors , Annual Report , Quarterly Reports , Aortic Valve Replacement With , Angiographic Assessment , Aortic Regurgitation Following , ஒன்றுபட்டது மாநிலங்களில் , ஏஞ்சலா மீனேோ , சூசி லிசா , பரிமாற்றம் தரகு , போஸ்டன் அறிவியல் நிறுவனம் , பத்திரங்கள் பரிமாற்றம் , போஸ்டன் அறிவியல் ,

BOSTON SCIENTIFIC INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Boston Scientific Corporation


Share this article
Share this article
NEW ORLEANS, April 30, 2021 /PRNewswire/  Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ( KSF ), announces that KSF has commenced an investigation into Boston Scientific Corporation (NYSE: BSX).  
On November 17, 2020, the Company announced a global recall of all unused inventory of its LOTUS Edge Aortic Valve System, due to complexities associated with the product delivery system, and that [g]iven the additional time and investment required to develop and reintroduce an enhanced delivery system, the company has chosen to retire the entire LOTUS product platform immediately. ....

New York , United States , New Orleans , Lewis Kahn , Charlesc Foti Jr , Boston Scientific Corporation , Boston Scientific , Kahn Swick Foti , Former Attorney General , Kahn Swick , Aortic Valve System , Class Period , Partner Lewis Kahn , Louisiana Attorney General Charles , Kahn Swick Amp Foti , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஆர்லீயந்ஸ் , லெவிஸ் கான் , போஸ்டன் அறிவியல் நிறுவனம் , போஸ்டன் அறிவியல் , கான் ஸ்விக் போடி , முன்னாள் வழக்கறிஞர் ஜநரல் , கான் ஸ்விக் , பெருநாடி அடைப்பான் அமைப்பு , வர்க்கம் காலம் ,